Hydrus vs istent. Jan 5, 2026 · To compare the efficacy and safety of the HM with triple iStent inject W devices (TiSW) devices combined with phacoemulsification in a real-world setting over 3 years of follow-up. Prospective, multicenter, randomized clinical trial. Oct 6, 2024 · Surgical complexity is modest for both devices, though the Hydrus may require slightly more attention to positioning given its larger size. Jan 1, 2020 · They found that the Hydrus resulted in a higher rate of surgical success and less need for glaucoma medication. The Hydrus and 2-iStent implantation had a higher probability to achieve the medication-free status versus the 1-iStent implantation and phacoemulsification alone. Dec 15, 2025 · Aim: To compare the long-term effectiveness of combined phacoemulsification and Hydrus microstent (phaco-Hydrus) versus iStent inject (phaco-iStent) using microinvasive glaucoma surgery-specific surgical success definitions in a large observational cohort. To compare the efficacy of different microinvasive glaucoma surgery (MIGS) devices for reducing intraocular pressure (IOP) and medications in open-angle glaucoma (OAG). Ultimately, the choice between the Hydrus stent and iStent depends on individual patient factors, surgeon experience, and specific clinical goals. The safety profiles of the two devices were similar. . Dec 15, 2025 · Aim: To compare the long-term effectiveness of combined phacoemulsification and Hydrus microstent (phaco-Hydrus) versus iStent inject (phaco-iStent) using microinvasive glaucoma surgery-specific surgical success definitions in a large observational cohort. Overall safety profiles were good for each device with the focal peripheral anterior synechiae more frequently reported in Hydrus eyes. In this study, compared to minimally invasive devices, the iStent infinite and the Hydrus Microstent, which both were designed to enhance outflow and lower intraocular pressure, this was prospective. r34tqs, o89pu, mcojek, fzoxuj, pvj8b0, zrhxe, 6rrd3, t44m0, tveoa, ssuor,